These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 2327768)
1. Ofloxacin versus co-trimoxazole for prevention of infection in neutropenic patients following cytotoxic chemotherapy. Liang RH; Yung RW; Chan TK; Chau PY; Lam WK; So SY; Todd D Antimicrob Agents Chemother; 1990 Feb; 34(2):215-8. PubMed ID: 2327768 [TBL] [Abstract][Full Text] [Related]
2. Infection prophylaxis in neutropenic patients with acute leukaemia--a randomized, comparative study with ofloxacin, ciprofloxacin and co-trimoxazole/colistin. Arning M; Wolf HH; Aul C; Heyll A; Scharf RE; Scheider W J Antimicrob Chemother; 1990 Nov; 26 Suppl D():137-42. PubMed ID: 2286588 [TBL] [Abstract][Full Text] [Related]
3. Prophylactic co-trimoxazole versus norfloxacin in neutropenic children--perspective randomized study. Cruciani M; Concia E; Navarra A; Perversi L; Bonetti F; Aricò M; Nespoli L Infection; 1989; 17(2):65-9. PubMed ID: 2654019 [TBL] [Abstract][Full Text] [Related]
4. Ofloxacin versus trimethoprim-sulfamethoxazole for prevention of infection in patients with acute leukemia and granulocytopenia. Kern W; Kurrle E Infection; 1991; 19(2):73-80. PubMed ID: 2050424 [TBL] [Abstract][Full Text] [Related]
5. Comparison of ciprofloxacin, ofloxacin and pefloxacin for the prevention of the bacterial infection in neutropenic patients with haematological malignancies. D'Antonio D; Piccolomini R; Iacone A; Fioritoni G; Parruti G; Betti S; Quaglietta AM; Accorsi P; Dell'Isola M; Favalli C J Antimicrob Chemother; 1994 Apr; 33(4):837-44. PubMed ID: 8056702 [TBL] [Abstract][Full Text] [Related]
6. Ofloxacin versus co-trimoxazole in the treatment of typhoid fever in children. Seçmeer G; Kanra G; Figen G; Akan O; Ceyhan M; Ecevit Z Acta Paediatr Jpn; 1997 Apr; 39(2):218-21. PubMed ID: 9141258 [TBL] [Abstract][Full Text] [Related]
7. Fosfomycin trometamol versus ofloxacin/co-trimoxazole as single dose therapy of acute uncomplicated urinary tract infection in females: a multicentre study. Naber KG; Thyroff-Friesinger U Infection; 1990; 18 Suppl 2():S70-6. PubMed ID: 2286465 [TBL] [Abstract][Full Text] [Related]
8. Spectrum and susceptibility of pathogens causing acute uncomplicated lower UTI in females and its correlation to bacteriologic outcome after single dose therapy with fosfomycin trometamol versus ofloxacin/co-trimoxazole. Naber KG; Thyroff-Friesinger U Infection; 1992; 20 Suppl 4():S296-301. PubMed ID: 1294521 [TBL] [Abstract][Full Text] [Related]
9. Selective gut decontamination with nalidixic acid or trimethoprim-sulfamethoxazole for infection prophylaxis in neutropenic cancer patients: relationship of efficacy to antimicrobial spectrum and timing of administration. Bow EJ; Rayner E; Scott BA; Louie TJ Antimicrob Agents Chemother; 1987 Apr; 31(4):551-7. PubMed ID: 3300532 [TBL] [Abstract][Full Text] [Related]
10. Quinolone-based antibacterial chemoprophylaxis in neutropenic patients: effect of augmented gram-positive activity on infectious morbidity. National Cancer Institute of Canada Clinical Trials Group. Bow EJ; Mandell LA; Louie TJ; Feld R; Palmer M; Zee B; Pater J Ann Intern Med; 1996 Aug; 125(3):183-90. PubMed ID: 8686975 [TBL] [Abstract][Full Text] [Related]
11. Kinetics and comparative efficacy of ofloxacin versus co-trimoxazole in the asymptomatic bacteriuria of elderly subjects. Giamarellou H; Iakovou M; Pistoni M; Petrikkos G; Dontas A; Sfikakis P Chemotherapy; 1991; 37 Suppl 1():19-24. PubMed ID: 2049961 [TBL] [Abstract][Full Text] [Related]
13. [Infection in patients with neutropenia that undergo an autologous peripheral blood stem cell transplant due to breast cancer]. Palau J; Picón I; Angel Climent M; Martí R; Aznar E; Carmen Sanjuán M; Máiquez J Enferm Infecc Microbiol Clin; 2001 Nov; 19(9):422-7. PubMed ID: 11709119 [TBL] [Abstract][Full Text] [Related]
14. Ofloxacin versus trimethoprim and co-trimoxazole in the treatment of uncomplicated urinary tract infection in general practice. Spencer RC; Cole TP Br J Clin Pract; 1992; 46(1):30-3. PubMed ID: 1419551 [TBL] [Abstract][Full Text] [Related]
15. Outbreak of co-trimoxazole- and gentamicin-resistant Klebsiella aerogenes bacteremia in neutropenic patients receiving oral co-trimoxazole prophylaxis. Leahy MF; Humble MW Aust N Z J Med; 1983 Dec; 13(6):636-8. PubMed ID: 6372773 [TBL] [Abstract][Full Text] [Related]
16. Co-trimoxazole alone for prevention of bacterial infection in patients with acute leukaemia. Starke ID; Donnelly P; Catovsky D; Darrell J; Johnson SA; Goldman JM; Galton DA Lancet; 1982 Jan; 1(8262):5-6. PubMed ID: 6119443 [TBL] [Abstract][Full Text] [Related]
17. Ofloxacin versus vancomycin/polymyxin for prevention of infections in granulocytopenic patients. Winston DJ; Ho WG; Bruckner DA; Gale RP; Champlin RE Am J Med; 1990 Jan; 88(1):36-42. PubMed ID: 2153006 [TBL] [Abstract][Full Text] [Related]
18. Limitations of and indications for the use of co-trimoxazole. Brumfitt W; Hamilton-Miller JM J Chemother; 1994 Feb; 6(1):3-11. PubMed ID: 8071675 [TBL] [Abstract][Full Text] [Related]
19. [Ofloxacin versus pipemidic acid and co-trimoxazole]. Wittenberger R Infection; 1986; 14 Suppl 1():S93-6. PubMed ID: 3514474 [TBL] [Abstract][Full Text] [Related]